113 related articles for article (PubMed ID: 31398438)
41. Formulation development of a plant-derived H1N1 influenza vaccine containing purified recombinant hemagglutinin antigen.
Iyer V; Liyanage MR; Shoji Y; Chichester JA; Jones RM; Yusibov V; Joshi SB; Middaugh CR
Hum Vaccin Immunother; 2012 Apr; 8(4):453-64. PubMed ID: 22370514
[TBL] [Abstract][Full Text] [Related]
42. Protective Immunity Against Homologous and Heterologous Influenza Virus Lethal Challenge by Immunization with New Recombinant Chimeric HA2-M2e Fusion Protein in BALB/C Mice.
Ameghi A; Pilehvar-Soltanahmadi Y; Baradaran B; Barzegar A; Taghizadeh M; Zarghami N; Aghaiypour K
Viral Immunol; 2016 May; 29(4):228-34. PubMed ID: 27058011
[TBL] [Abstract][Full Text] [Related]
43. Ovalbumin-coated pH-sensitive microneedle arrays effectively induce ovalbumin-specific antibody and T-cell responses in mice.
van der Maaden K; Varypataki EM; Romeijn S; Ossendorp F; Jiskoot W; Bouwstra J
Eur J Pharm Biopharm; 2014 Oct; 88(2):310-5. PubMed ID: 24820032
[TBL] [Abstract][Full Text] [Related]
44. Insertion-responsive microneedles for rapid intradermal delivery of canine influenza vaccine.
Choi IJ; Kang A; Ahn MH; Jun H; Baek SK; Park JH; Na W; Choi SO
J Control Release; 2018 Sep; 286():460-466. PubMed ID: 30102940
[TBL] [Abstract][Full Text] [Related]
45. Immune responses to intradermal and intramuscular inactivated influenza vaccine among older age group.
Boonnak K; Dhitavat J; Thantamnu N; Kosoltanapiwat N; Auayporn M; Jiang L; Puthavathana P; Pitisuttithum P
Vaccine; 2017 Dec; 35(52):7339-7346. PubMed ID: 29157960
[TBL] [Abstract][Full Text] [Related]
46. [Increasing the immunogenicity of inactivated chitosan adjuvanted vaccine from A/California/7/09 (H1N1) strain and analyzing the antigenic specificity of this influenza virus strain].
Gendon IuZ; Markushin SG; Vasil'ev IuM; Akopova II; Krivtsov GG
Vopr Virusol; 2012; 57(1):28-33. PubMed ID: 22624470
[TBL] [Abstract][Full Text] [Related]
47. Ovalbumin and cholera toxin delivery to buccal mucus for immunization using microneedles and comparison of immunological response to transmucosal delivery.
Oh YJ; Cha HR; Hwang SJ; Kim DS; Choi YJ; Kim YS; Shin YR; Nguyen TT; Choi SO; Lee JM; Park JH
Drug Deliv Transl Res; 2021 Aug; 11(4):1390-1400. PubMed ID: 33759112
[TBL] [Abstract][Full Text] [Related]
48. Microneedle delivery of trivalent influenza vaccine to the skin induces long-term cross-protection.
Kim YC; Lee SH; Choi WH; Choi HJ; Goo TW; Lee JH; Quan FS
J Drug Target; 2016 Dec; 24(10):943-951. PubMed ID: 26957023
[TBL] [Abstract][Full Text] [Related]
49. Immunogenicity and safety of cell-derived MF59®-adjuvanted A/H1N1 influenza vaccine for children.
Knuf M; Leroux-Roels G; Rümke H; Rivera L; Pedotti P; Arora AK; Lattanzi M; Kieninger D; Cioppa GD
Hum Vaccin Immunother; 2015; 11(2):358-76. PubMed ID: 25621884
[TBL] [Abstract][Full Text] [Related]
50. Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.
Goff PH; Hayashi T; He W; Yao S; Cottam HB; Tan GS; Crain B; Krammer F; Messer K; Pu M; Carson DA; Palese P; Corr M
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724768
[TBL] [Abstract][Full Text] [Related]
51. Identification of antigen and adjuvant doses resulting in optimal immunogenicity and antibody persistence up to 1 year after immunization with a pandemic A/H1N1 influenza vaccine in children 3 to < 9 years of age.
Nassim C; Christensen S; Henry D; Holmes S; Hohenboken M; Kanesa-Thasan N
Pediatr Infect Dis J; 2012 Apr; 31(4):e59-65. PubMed ID: 22418661
[TBL] [Abstract][Full Text] [Related]
52. Mannan adjuvants intranasally administered inactivated influenza virus in mice rendering low doses inductive of strong serum IgG and IgA in the lung.
Proudfoot O; Esparon S; Tang CK; Laurie K; Barr I; Pietersz G
BMC Infect Dis; 2015 Feb; 15():101. PubMed ID: 25887952
[TBL] [Abstract][Full Text] [Related]
53. Safety, tolerability, acceptability and immunogenicity of an influenza vaccine delivered to human skin by a novel high-density microprojection array patch (Nanopatch™).
Fernando GJP; Hickling J; Jayashi Flores CM; Griffin P; Anderson CD; Skinner SR; Davies C; Witham K; Pryor M; Bodle J; Rockman S; Frazer IH; Forster AH
Vaccine; 2018 Jun; 36(26):3779-3788. PubMed ID: 29779922
[TBL] [Abstract][Full Text] [Related]
54. [Estimation of human and animal immunological memory by testing the trogocytosis of virus-specific T lymphocytes].
Naĭkhin AN; Koren'kov DA; Chirkova TV; Petukhova GD; Donina SA; Rudenko LG
Vopr Virusol; 2011; 56(5):15-21. PubMed ID: 22171472
[TBL] [Abstract][Full Text] [Related]
55. Transcutaneous immunization of Streptococcus suis bacterin using dissolving microneedles.
Hsueh KJ; Chen MC; Cheng LT; Lee JW; Chung WB; Chu CY
Comp Immunol Microbiol Infect Dis; 2017 Feb; 50():78-87. PubMed ID: 28131383
[TBL] [Abstract][Full Text] [Related]
56. Fabrication of cell culture-derived influenza vaccine dissolvable microstructures and evaluation of immunogenicity in guinea pigs.
Bonificio A; Ghartey-Tagoe E; Gallorini S; Baudner B; Chen G; Singh P; O'Hagan DT; Kommareddy S
Vaccine; 2015 Jun; 33(25):2930-8. PubMed ID: 25930118
[TBL] [Abstract][Full Text] [Related]
57. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.
Hsu JP; Phoon MC; Koh GC; Chen MI; Lee VJ; Wu Y; Xie ML; Cheong A; Leo YS; Chow VT
Int J Infect Dis; 2012 Aug; 16(8):e621-7. PubMed ID: 22704721
[TBL] [Abstract][Full Text] [Related]
58. Protective and cross-protective mucosal immunization of mice by influenza virus type A with bacterial adjuvant.
Zanvit P; Havlícková M; Tácner J; Novotná O; Jirkovská M; Cechová D; Julák J; Sterzl I; Prokesová L
Immunol Lett; 2008 Jan; 115(2):144-52. PubMed ID: 18160106
[TBL] [Abstract][Full Text] [Related]
59. Stabilization of HAC1 influenza vaccine by spray drying: formulation development and process scale-up.
Zhu C; Shoji Y; McCray S; Burke M; Hartman CE; Chichester JA; Breit J; Yusibov V; Chen D; Lal M
Pharm Res; 2014 Nov; 31(11):3006-18. PubMed ID: 24858396
[TBL] [Abstract][Full Text] [Related]
60. Immune responses of mice to influenza subunit vaccine in combination with CIA07 as an adjuvant.
Park SA; Song ES; Cho YJ; Ahn BY; Ha SH; Seong BL; Lee KH; Lee NG
Microbiol Immunol; 2007; 51(11):1099-107. PubMed ID: 18037787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
